Total Payments
$75,453
2024 Payments
$4,393
Companies
60
Transactions
586
Medicare Patients
1,257
Medicare Billing
$153,623
Payment Breakdown by Category
Consulting$44,379 (58.8%)
Food & Beverage$18,106 (24.0%)
Travel$8,511 (11.3%)
Other$4,115 (5.5%)
Education$342.57 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $44,379 | 23 | 58.8% |
| Food and Beverage | $18,106 | 518 | 24.0% |
| Travel and Lodging | $8,511 | 27 | 11.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,965 | 4 | 5.3% |
| Education | $342.57 | 13 | 0.5% |
| Honoraria | $150.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $9,546 | 62 | $0 (2022) |
| Celgene Corporation | $8,466 | 28 | $0 (2021) |
| Gilead Sciences, Inc. | $8,065 | 18 | $0 (2019) |
| ImmunoGen, Inc. | $5,941 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $5,759 | 13 | $0 (2021) |
| Incyte Corporation | $4,845 | 14 | $0 (2023) |
| Rigel Pharmaceuticals, Inc. | $4,515 | 12 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $3,702 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,249 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,734 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,393 | 14 | Bayer Healthcare Pharmaceuticals Inc. ($1,710) |
| 2023 | $6,782 | 14 | ImmunoGen, Inc. ($5,941) |
| 2022 | $1,321 | 13 | AstraZeneca Pharmaceuticals LP ($337.96) |
| 2021 | $4,361 | 20 | GlaxoSmithKline, LLC. ($1,968) |
| 2020 | $2,619 | 31 | Verastem, Inc. ($1,320) |
| 2019 | $23,899 | 181 | Celgene Corporation ($7,915) |
| 2018 | $19,191 | 173 | Daiichi Sankyo Inc. ($5,498) |
| 2017 | $12,887 | 140 | Genentech USA, Inc. ($5,400) |
All Payment Transactions
586 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $91.79 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,710.00 | General |
| Category: Oncology | ||||||
| 10/02/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $121.18 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $120.90 | General |
| Category: Oncology | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $121.18 | General |
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 06/13/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $51.49 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $111.79 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $131.00 | General |
| Category: Oncology | ||||||
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Oncology | ||||||
| 04/16/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $117.72 | General |
| Category: ONCOLOGY | ||||||
| 12/27/2023 | ImmunoGen, Inc. | Elahere (Biological) | Consulting Fee | Cash or cash equivalent | $5,861.37 | General |
| Category: Oncology | ||||||
| 12/13/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $85.13 | General |
| Category: Oncology | ||||||
| 12/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $37.73 | General |
| Category: Oncology | ||||||
| 12/08/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Oncology | ||||||
| 12/08/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Oncology | ||||||
| 10/25/2023 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $124.26 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/05/2023 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $127.58 | General |
| Category: Hematology | ||||||
| 10/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 08/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | EXKIVITY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 294 | 664 | $78,780 | $36,823 |
| 2022 | 4 | 271 | 698 | $69,655 | $36,150 |
| 2021 | 5 | 346 | 824 | $82,702 | $47,200 |
| 2020 | 6 | 346 | 819 | $74,770 | $33,449 |
Total Patients
1,257
Total Services
3,005
Medicare Billing
$153,623
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 200 | $30,810 | $13,880 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 264 | $23,376 | $10,891 | 46.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 68 | $7,412 | $4,107 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 71 | $6,282 | $3,036 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $5,713 | $2,607 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 32 | $5,187 | $2,304 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 364 | $30,503 | $15,413 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 178 | $22,092 | $12,123 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 90 | $7,578 | $4,201 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $5,122 | $2,251 | 43.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 40 | $4,360 | $2,162 | 49.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 160 | 406 | $31,262 | $18,220 | 58.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 223 | $26,537 | $15,920 | 60.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 46 | 88 | $6,776 | $4,223 | 62.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $8,192 | $3,737 | 45.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 55 | $5,995 | $3,031 | 50.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $3,940 | $2,070 | 52.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 488 | $37,576 | $16,478 | 43.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 72 | 135 | $10,395 | $4,588 | 44.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 39 | 80 | $8,720 | $4,290 | 49.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 57 | $6,783 | $3,200 | 47.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 27 | 27 | $6,912 | $2,979 | 43.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 12 | $3,684 | $1,733 | 47.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Facility | 2020 | 19 | 20 | $700.00 | $180.42 | 25.8% |
About Dr. Gregory Smith, MD
Dr. Gregory Smith, MD is a Hematology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225007842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Smith, MD has received a total of $75,453 in payments from pharmaceutical and medical device companies, with $4,393 received in 2024. These payments were reported across 586 transactions from 60 companies. The most common payment nature is "Consulting Fee" ($44,379).
As a Medicare-enrolled provider, Smith has provided services to 1,257 Medicare beneficiaries, totaling 3,005 services with total Medicare billing of $153,623. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Indianapolis, IN
- Active Since 03/16/2006
- Last Updated 09/06/2023
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1225007842
Products in Payments
- Zydelig (Drug) $7,971
- Pomalyst (Drug) $7,897
- Elahere (Biological) $5,941
- Herceptin (Biological) $4,784
- Tavalisse (Drug) $4,515
- Onivyde (Drug) $3,667
- Alecensa (Biological) $3,509
- Erleada (Drug) $2,043
- ZEJULA (Drug) $1,787
- Vitrakvi (Drug) $1,724
- Copiktra (Drug) $1,331
- IMFINZI (Drug) $1,254
- OPDIVO (Biological) $832.01
- TAGRISSO (Drug) $811.47
- OJJAARA (Drug) $650.00
- Reblozyl (Drug) $650.00
- Braftovi (Drug) $600.00
- TECENTRIQ (Biological) $594.49
- LYNPARZA (Drug) $581.00
- JEVTANA (Drug) $543.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Indianapolis
Dr. Luke Akard, M.d, M.D
Hematology — Payments: $510,050
Hematology $510,050
Attaya Suvannasankha, M.d, M.D
Hematology — Payments: $224,074
Hematology $224,074
Bert O'neil, Md, MD
Hematology — Payments: $160,161
Hematology $160,161
Felix Mensah, Md, MD
Hematology — Payments: $114,460
Hematology $114,460
Pablo Bedano, Md, MD
Hematology — Payments: $56,782
Hematology $56,782
Sumeet Bhatia, Md, MD
Hematology — Payments: $24,304
Hematology $24,304